CD80 and Huntington disease: The cDC2 subset responded to Poly(I:C) by increasing the expression of CD40 and CD80 in HD, but this response was weaker in all patient groups (Figures 4D–F), suggesting that the cDC2 subset may also be functionally impaired in patients with OvC independently of treatment.